INR 909.8
(-1.02%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 2.27 Billion INR | -31.54% |
2022 | 3.31 Billion INR | 15.52% |
2021 | 2.87 Billion INR | 40.42% |
2020 | 2.04 Billion INR | 31.79% |
2019 | 1.55 Billion INR | 19.75% |
2018 | 1.29 Billion INR | 316.56% |
2017 | 311.06 Million INR | -25.97% |
2016 | 420.16 Million INR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 1.24 Billion INR | 10.54% |
2024 Q1 | 604.46 Million INR | -4.51% |
2023 Q3 | 1.05 Billion INR | 6.34% |
2023 Q4 | 633 Million INR | -40.03% |
2023 Q1 | 944.24 Million INR | 3.15% |
2023 FY | 2.27 Billion INR | -31.54% |
2023 Q2 | 992.71 Million INR | 5.13% |
2022 Q3 | 824.63 Million INR | -2.22% |
2022 Q1 | 734.02 Million INR | 3.8% |
2022 Q4 | 915.4 Million INR | 11.01% |
2022 Q2 | 843.33 Million INR | 14.89% |
2022 FY | 3.31 Billion INR | 15.52% |
2021 Q4 | 707.15 Million INR | 5.1% |
2021 FY | 2.87 Billion INR | 40.42% |
2021 Q3 | 672.83 Million INR | 0.03% |
2021 Q2 | 672.62 Million INR | -17.88% |
2021 Q1 | 819.02 Million INR | 36.67% |
2020 Q4 | 599.28 Million INR | 0.0% |
2020 FY | 2.04 Billion INR | 31.79% |
2019 FY | 1.55 Billion INR | 19.75% |
2019 Q4 | 582.88 Million INR | 0.0% |
2018 FY | 1.29 Billion INR | 316.56% |
2017 FY | 311.06 Million INR | -25.97% |
2016 FY | 420.16 Million INR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Dr. Lal PathLabs Limited | 14.62 Billion INR | 84.466% |
Metropolis Healthcare Limited | 5.81 Billion INR | 60.931% |
Thyrocare Technologies Limited | 2.5 Billion INR | 9.267% |
Vijaya Diagnostic Centre Limited | 4.82 Billion INR | 52.917% |
Vimta Labs Limited | 1.08 Billion INR | -108.924% |